• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.750 -2.960 (-30.48%)
Official Closing Price Updated: 4:10 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 Next >
News headline image
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
September 04, 2025
From Ginkgo Bioworks
Via Business Wire
News headline image
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
May 08, 2025
From Twist Bioscience Corporation
Via Business Wire
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
March 19, 2024
Via AB Newswire
Topics Supply Chain
News headline image
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
February 28, 2024
From bit.bio
Via Business Wire
TheStreetReports: AI Biomedical Companies Disrupting Healthcare: INBS, DNA, IBRX, CDIO
May 30, 2023
Via AB Newswire
Topics Artificial Intelligence
News headline image
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Investor Notice: Investigation over Potential Wrongdoing ↗
April 25, 2023
San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Ginkgo Bioworks Holdings, Inc.. 
Via SBWire
News headline image
Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 27, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ginkgo Bioworks Holdings, Inc. - DNA
March 25, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 01, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
February 28, 2023
From Cronos Group Inc.
Via GlobeNewswire
News headline image
To The Moon: Intuitive Machines Blasts 10x in a Week...But Why?
February 28, 2023
The modern version of the Cold War Space Race has implications for scientific discovery and satellite communications. Intuitive Machines is in the thick of it. 
Via MarketBeat
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation
February 21, 2023
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Investigation Announced for Investors Who Lost Money with NYSE: DNA Shares over Possible Violations of Securities Laws by Ginkgo Bioworks Holdings, Inc. ↗
February 01, 2023
San Diego, CA -- (SBWIRE) -- 02/01/2023 -- An investigation was announced for investors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares over potential securities laws violations by Ginkgo Bioworks... 
Via SBWire
News headline image
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 27, 2023
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
ZYMERGEN ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of ZY and Encourages Investors to Contact the Firm
July 26, 2022
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sharps Compliance Corp. (Nasdaq - SMED), Infrastructure and Energy Alternatives, Inc. (Nasdaq - IEA), AutoWeb, Inc. (Nasdaq - AUTO), Zymergen Inc. (Nasdaq - ZY)
July 25, 2022
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
NYSE:DNA Long Term Investor Alert: Investigation of Potential Wrongdoing at Ginkgo Bioworks Holdings, Inc. ↗
April 13, 2022
San Diego, CA -- (SBWIRE) -- 04/13/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Ginkgo Bioworks Holdings, Inc. 
Via SBWire
News headline image
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
April 05, 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Final Deadline Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
DNA; SRNG Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors With Losses Exceeding $200K of Class Action
January 18, 2022
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Deadline Tomorrow Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 17, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
GINKGO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors to Contact the Firm
January 17, 2022
From Bragar Eagel & Squire, P.C.
Via Business Wire
Deadline Tuesday Notice: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 14, 2022
Los Angeles - (NewMediaWire) - January 14, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ginkgo Bioworks Holdings, Inc.... 
Via NewMediaWire
Topics Lawsuit
News headline image
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc.
January 14, 2022
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
Deadline Tuesday Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Tuesday Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 12, 2022
Los Angeles - (NewMediaWire) - January 12, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ginkgo Bioworks Holdings, Inc.... 
Via NewMediaWire
Topics Lawsuit
7-Day Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 11, 2022
Los Angeles - (NewMediaWire) - January 11, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ginkgo Bioworks Holdings, Inc.... 
Via NewMediaWire
Topics Lawsuit
News headline image
Ginkgo Bioworks Adopts Inscripta’s Onyx Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput
January 10, 2022
From Inscripta
Via Business Wire
News headline image
Upcoming Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 31, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Shareholder Action Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
December 30, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap